Both in Pharmaceuticals
Bristol-Myers Squibb vs Merck & Co.
Over the past year BMY returned +35.8% and MRK returned +81.3%; their daily moves had a correlation of 0.48.
BMY +35.8% MRK +81.3%Growth of $1, one year, split-adjusted
| Metric | BMY | MRK |
|---|---|---|
| Price | $62.48 | $149.52 |
| Market cap | $127.71B | $368.89B |
| Today | +1.78% | +2.18% |
| 1 month | +1.7% | +4.0% |
| 6 months | +7.3% | +33.3% |
| Year to date | +15.8% | +42.0% |
| 1 year | +46.7% | +72.7% |
| Revenue growth (YoY) | +5.7% | +5.1% |
| Gross margin | 71.3% | 73.5% |
| Net margin | 25.6% | −8.0% |
| P/E (TTM) | 13.8× | 116.3× |
| Price / sales | 2.6× | 5.5× |
| Net cash | -$32.05B | -$46.77B |
| Dividend yield | 4.03% | 2.27% |
| Volatility (60d) | 27.3% | 36.0% |
| Short % of float | 2.4% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).